PharmaJet®, a company that strives to improve the performance and outcomes of injectables with its enabling needle-free injection technology, announced that the WHO prequalified Tropis ID delivery system will be used to support a polio eradication campaign sponsored by the National Emergency ...

GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., announced that via a collaboration with Novo Nordisk, all strengths of Ozempic® (semaglutide) and Wegovy® (semaglutide) pens are available to eligible self-paying patients for $499-per-month through GoodRx, effective ...

PICO IV, the pioneers behind the world's first sterile CBD emulsion, have announced a strategic partnership with Liquivida®, a national leader in IV therapy and wellness. This partnership marks an exciting turn for both companies as they continue to innovate in IV hydration while upholding the ...

Switch Bioworks, a biotechnology company developing low-cost and sustainable fertilizers, announced the addition of two senior leaders to its executive team and a move into a new, dedicated corporate headquarters and R&D facility in San Carlos, California.

Steve del Cardayre, PhD, joins as ...

Daewoong Pharmaceutical (Co-CEOs Seong-Soo Park and Chang-Jae Lee) and Daewoong Therapeutics (CEO Bok-Ki Kang) announced that their proprietary semaglutide microneedle patch achieved more than 80%relative bioavailability compared to the injectable formulation in a pilot human pharmacokinetic study.

Jazz Pharmaceuticals plc announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Modeyso™ (dordaviprone) for the treatment of adult and pediatric patients 1 year of age and older with diffuse midline glioma harboring an H3 K27M mutation with progressive ...